# Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy

> **NCT04133532** · PHASE4 · COMPLETED · sponsor: **University Hospital, Motol** · enrollment: 22 (actual)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **DRUG:** Metoprolol

## Key facts

- **NCT ID:** NCT04133532
- **Lead sponsor:** University Hospital, Motol
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-05
- **Primary completion:** 2023-02-23
- **Final completion:** 2023-02-23
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04133532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04133532, "Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04133532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*